[Prospective treatment study of irbesartan. Diabetic kidneys regain function].
Lehnert
H
H
Klinik für Endokrinologie und Stoffwechselkrankheiten, Medizinische Fakultät, Otto-von-Guericke-Universität, Leipziger Strasse 44, D-39120 Magdeburg. Hendrik.Lehnert@medizin.uni-magdeburg.de
Bramlage
P
P
Pittrow
D
D
Kirch
W
W
D000419:Albuminuria / Q000188:drug therapy; D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003928:Diabetic Nephropathies / Q000188:drug therapy*; D005500:Follow-Up Studies; D006801:Humans; D000077405:Irbesartan; D007677:Kidney Function Tests; D013777:Tetrazoles / Q000627:therapeutic use*
D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D013777:Tetrazoles; D000077405:Irbesartan